These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24059587)

  • 21. Application of microRNAs in diabetes mellitus.
    Chen H; Lan HY; Roukos DH; Cho WC
    J Endocrinol; 2014 Jul; 222(1):R1-R10. PubMed ID: 24781254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs: the underlying mediators of pathogenetic processes in vascular complications of diabetes.
    Ruiz MA; Chakrabarti S
    Can J Diabetes; 2013 Oct; 37(5):339-44. PubMed ID: 24500562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of MicroRNAs in Diabetes and Its Complications.
    Wu B; Miller D
    Methods Mol Biol; 2017; 1617():225-239. PubMed ID: 28540689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats.
    Gandhi S; Srinivasan B; Akarte AS
    J Renin Angiotensin Aldosterone Syst; 2013 Mar; 14(1):3-13. PubMed ID: 22791702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of microRNAs in the pathogenesis of diabetes.
    Park SY; Jeong HJ; Yang WM; Lee W
    Arch Pharm Res; 2013 Feb; 36(2):154-66. PubMed ID: 23361585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
    Klein S; Fontana L; Young VL; Coggan AR; Kilo C; Patterson BW; Mohammed BS
    N Engl J Med; 2004 Jun; 350(25):2549-57. PubMed ID: 15201411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of microRNAs in diabetes and its cardiovascular complications.
    Shantikumar S; Caporali A; Emanueli C
    Cardiovasc Res; 2012 Mar; 93(4):583-93. PubMed ID: 22065734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis.
    Murdolo G; Smith U
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S35-8. PubMed ID: 16530128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular medicine of microRNAs: structure, function and implications for diabetes.
    Hennessy E; O'Driscoll L
    Expert Rev Mol Med; 2008 Aug; 10():e24. PubMed ID: 18702835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inflammatory process of adipose tissue.
    Blüher M
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):24-31. PubMed ID: 18806722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
    Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K
    Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver: a target of late diabetic complications.
    Herzig S
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):202-4. PubMed ID: 22402949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6 and insulin resistance.
    Kim JH; Bachmann RA; Chen J
    Vitam Horm; 2009; 80():613-33. PubMed ID: 19251052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of hyperglycemia in Zucker diabetic fatty rats by exercise training: effects on gene expression in insulin-sensitive tissues determined by high-density oligonucleotide microarray analysis.
    Colombo M; Gregersen S; Kruhoeffer M; Agger A; Xiao J; Jeppesen PB; Orntoft T; Ploug T; Galbo H; Hermansen K
    Metabolism; 2005 Dec; 54(12):1571-81. PubMed ID: 16311088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity, inflammation, and insulin resistance--a mini-review.
    Zeyda M; Stulnig TM
    Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.